MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Pumping Stopped (1503)
|
Patient Problems
Diarrhea (1811); Nausea (1970); Anxiety (2328); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 09/03/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider (hcp) via a company representative (rep) regarding a patient receiving dilaudid (5mg/ml, 2.38 mg/day), bupivacaine (0.5 mg/ml, 0.238 mg/day) via an implantable pump for spinal pain.It was reported that the patient¿s pump began critically alarming on the morning of (b)(6) 2021.The patient was seen in the clinic and pump interrogation logs showed that the pump had motor stalled at 2:47am.The patient was feeling withdrawal symptoms - nauseous, diarrhea, anxious.There was no mri or other magnetic contact.The pump was interrogated.Waited 2+ hours for pump to recover from stall but pump did not recover.The patient was prescribed oral dilaudid until patient could be scheduled to replace pump.The pump was permanently shut down as per hcp direction.The issue was not resolved at the time of this report.The patient's weight and medical history were asked but will not be made available.The patient was alive with no injury at the time of this report.Additional information was received from the company representative that the cause of the pump motor stall was unknown.The patient had no contact with mri or magnetic devices that would have caused the motor stall.The device¿s therapy was permanently discontinued and was not being used.Oral therapy was prescribed as a result and the explant and replacement will be scheduled.
|
|
Event Description
|
Additional information received reported that the pump was replaced today.The replacement surgery went as expected.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|